Cover Image
市場調查報告書

PharmaPoint:大腸癌症--現在、未來市場參與企業

PharmaPoint: Colorectal Cancer - Current and Future Players

出版商 GlobalData 商品編碼 321693
出版日期 內容資訊 英文 59 Pages
訂單完成後即時交付
價格
Back to Top
PharmaPoint:大腸癌症--現在、未來市場參與企業 PharmaPoint: Colorectal Cancer - Current and Future Players
出版日期: 2014年11月28日 內容資訊: 英文 59 Pages
簡介

本報告提供全球大腸癌症相關市場上現有企業及新加入企業相關分析、整體市場的未來展望和促進、阻礙因素、現在、未來的競爭趨勢、主要企業簡介(營業內容、產品開發情形、SWOT分析)等調查、考察。

第1章 目錄

第2章 簡介

  • 分析的背景情況
  • 相關報告
  • 出版預定的相關調查報告

第3章 市場預測

  • 全球市場
    • 預測
    • 推動因素、阻礙因素:全世界的問題

第4章 現在及未來的主要企業

  • 概要
  • 企業策略趨勢
  • 企業簡介
    • Roche/Genentech
    • Sanofi
    • Eli Lilly and Company
    • Merck KGaA
    • Bayer
    • 大鵬藥品工業

第5章 附錄

圖表一覽

目錄
Product Code: GDHC1039FPR

GlobalData has released its pharma report, "PharmaPoint: Colorectal Cancer - Current and Future Players". The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Colorectal Cancer Market. The report identifies and analyses the key companies shaping and driving the global Colorectal Cancer market. The report provides insight into the competitive Colorectal Cancer landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalData's team of industry experts.

Scope

  • Investigation of current and future market competition for Colorectal Cancer
  • Competitor assessment
  • Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
  • Strategic assessment of Colorectal Cancer sector through market impact analysis, future market scenario and company analysis

Reasons to buy

  • Gain a high level view of the trends shaping and driving Colorectal Cancer market
  • Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
  • Create an effective counter-strategy to gain a competitive advantage against those currently in the market
  • What's the next big thing in the global Colorectal Cancer market landscape? Identify, understand and capitalize

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Catalyst
  • 2.2. Related Reports
  • 2.3. Upcoming Related Reports

3. Market Outlook

  • 3.1. Global Markets
    • 3.1.1. Forecast
    • 3.1.2. Drivers and Barriers - Global Issues

4. Current and Future Players

  • 4.1. Overview
  • 4.2. Trends in Corporate Strategy
  • 4.3. Company Profiles
    • 4.3.1. Roche/Genentech
    • 4.3.2. Sanofi
    • 4.3.3. Eli Lilly and Company
    • 4.3.4. Merck KGaA
    • 4.3.5. Bayer
    • 4.3.6. Taiho Pharmaceutical

5. Appendix

  • 5.1. Bibliography
  • 5.2. Abbreviations
  • 5.3. Methodology
  • 5.4. Forecasting Methodology
    • 5.4.1. Diagnosed Colorectal Cancer Patients
    • 5.4.2. Percent Drug-Treated Patients
    • 5.4.3. General Pricing Assumptions
    • 5.4.4. Average Body Weight and Surface Area Across the 8MM
    • 5.4.5. Generic Erosion
  • 5.5. Primary Research - KOLs Interviewed for this Report
  • 5.6. Primary Research - Prescriber Survey
  • 5.7. About the Authors
    • 5.7.1. Analyst
    • 5.7.2. Global Head of Healthcare
  • 5.8. About GlobalData
  • 5.9. Disclaimer

List of Tables

  • Table 1: Sales Forecasts ($m) for Colorectal Cancer in the Global Markets, 2013-2023
  • Table 2: CRC Market Drivers and Barriers, 2014
  • Table 3: Key Companies in the CRC Market in the 8MM, 2013-2023
  • Table 4: Roche's CRC Portfolio Assessment, 2014
  • Table 5: Sanofi's CRC Portfolio Assessment, 2014
  • Table 6: Eli Lilly's CRC Portfolio Assessment, 2014
  • Table 7: Merck KGaA's CRC Portfolio Assessment, 2014
  • Table 8: Bayer's CRC Portfolio Assessment, 2014
  • Table 9: Taiho's CRC Portfolio Assessment, 2014
  • Table 10: Average Body Weight and Surface Area Across the 8MM
  • Table 11: High-Prescribing Physicians (non-KOLs) Surveyed, By Country

List of Figures

  • Figure 1: Global Sales for Colorectal Cancer by Region, 2013-2023
  • Figure 2: Global Sales of Branded Products for Colorectal Cancer by Company, 2013-2023
  • Figure 3: Company Portfolio Gap Analysis in CRC, 2013-2023
  • Figure 4: Roche SWOT Analysis in CRC, 2014
  • Figure 5: Sanofi SWOT Analysis in CRC, 2014
  • Figure 6: Eli Lilly SWOT Analysis in CRC, 2014
  • Figure 7: Merck KGaA SWOT Analysis in CRC, 2014
  • Figure 8: Bayer SWOT Analysis in CRC, 2014
  • Figure 9: Taiho SWOT Analysis in CRC, 2014
Back to Top